- Home
- EMBC vs ZONE Comparison
EMBC vs ZONE Comparison
Compare EMBC & ZONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- ZONE
- Stock Information
- Founded
- EMBC 1924
- ZONE 2022
- Country
- EMBC United States
- ZONE United States
- Employees
- EMBC N/A
- ZONE N/A
- Industry
- EMBC Medical/Dental Instruments
- ZONE
- Sector
- EMBC Health Care
- ZONE
- Exchange
- EMBC Nasdaq
- ZONE NYSE
- Market Cap
- EMBC 716.2M
- ZONE N/A
- IPO Year
- EMBC N/A
- ZONE 2024
- Fundamental
- Price
- EMBC $13.30
- ZONE $1.64
- Analyst Decision
- EMBC Hold
- ZONE
- Analyst Count
- EMBC 3
- ZONE 0
- Target Price
- EMBC $17.67
- ZONE N/A
- AVG Volume (30 Days)
- EMBC 423.5K
- ZONE 82.6K
- Earning Date
- EMBC 05-09-2025
- ZONE 06-09-2025
- Dividend Yield
- EMBC 4.51%
- ZONE N/A
- EPS Growth
- EMBC 2.96
- ZONE N/A
- EPS
- EMBC 0.99
- ZONE N/A
- Revenue
- EMBC $1,107,700,000.00
- ZONE $1,643,051.00
- Revenue This Year
- EMBC N/A
- ZONE N/A
- Revenue Next Year
- EMBC $0.99
- ZONE N/A
- P/E Ratio
- EMBC $13.44
- ZONE N/A
- Revenue Growth
- EMBC N/A
- ZONE N/A
- 52 Week Low
- EMBC $10.12
- ZONE $0.81
- 52 Week High
- EMBC $21.48
- ZONE $3.57
- Technical
- Relative Strength Index (RSI)
- EMBC 60.26
- ZONE N/A
- Support Level
- EMBC $12.08
- ZONE N/A
- Resistance Level
- EMBC $12.76
- ZONE N/A
- Average True Range (ATR)
- EMBC 0.50
- ZONE 0.00
- MACD
- EMBC 0.20
- ZONE 0.00
- Stochastic Oscillator
- EMBC 94.27
- ZONE 0.00
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.